Riskpilot← Back to searchSign inGet full accessValerokliniken AB
ABActiveOrg 5592968183Bergklevet 7 BPhysiotherapy activities · NACE 8695Est. 20212 employees
Revenue 2025
SEK 1,2M
-6% vs 2024
EBITDA margin
-2.7%
-141% vs 2024
Equity ratio
52.3%
Financial strength
Net profit 2025
SEK -61K
-221% vs 2024
| Revenue | SEK 1,2M | -6% |
| EBITDA | SEK -33K | -141% |
| Net profit | SEK -61K | -221% |
| Total assets | SEK 392K | -4% |
| Equity | SEK 205K | -23% |
| Employees | 2 | — |
Legal name
Valerokliniken AB
Org number
5592968183
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
15 januari 2021
Share capital
SEK 25 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva kiropraktisk behandling, läkarvård, rehabilitering, friskvård, massage samt försäljning av hjälpmedel, träningsprodukter, sjukvårdsartiklar och kosttillskott, föreläsning och utbildning inom kiropraktik, hälsa och sjukvård samt äga och förvalta fastigheter, uthyrning av lokal, förvaltning av värdepapper samt därmed förenlig verksamhet.
Address
Bergklevet 7 B
Email
dd@valero.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 912 | 1 787 | 1 435 | 1 306 | 1 227 |
| Staff expenses | — | −758 | −851 | −733 | −843 |
| EBITDA | 85 | 343 | −49 | 80 | −33 |
| Depreciation & amort. | −28 | −28 | −28 | −28 | −28 |
| EBIT | 57 | 315 | −77 | 52 | −61 |
| Net financials | −7 | −9 | −9 | −1 | 0 |
| Profit before tax | 49 | 307 | −87 | 51 | −61 |
| Tax | −12 | −66 | — | −1 | — |
| Net profit | 37 | 241 | −87 | 50 | −61 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 666 | 641 | 510 | 410 | 392 |
| Equity | 62 | 303 | 216 | 266 | 205 |
| Long-term debt | 216 | 171 | 121 | 0 | — |
| Short-term debt | 388 | 167 | 174 | 144 | 187 |
| Total debt | 604 | 338 | 294 | 144 | 187 |
EBITDA margin
-2.7%
This company
15.8%
Market median
-117% vs market
20212025
Equity ratio
52.3%
This company
38.2%
Market median
+37% vs market
20212025
Return on equity
-29.6%
This company
18.4%
Market median
-261% vs market
20212025
Net profit margin
-5.0%
This company
8.1%
Market median
-162% vs market
20212025
Asset turnover
3.13×
This company
1.12×
Market median
+179% vs market
20212025
Debt / equity
0.91×
This company
0.62×
Market median
+47% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Valerokliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Gunnar Rickard Dyrvold | Deputy Board Member | 0 companies |
| Dennis Martin Dyrvold | Board of Directors | 0 companies |